Literature DB >> 29113006

Transjugular portal vein recanalization with creation of intrahepatic portosystemic shunt (PVR-TIPS) in patients with chronic non-cirrhotic, non-malignant portal vein thrombosis.

Christoph Klinger1, Bettina Riecken1, Arthur Schmidt1,2, Andrea De Gottardi3, Benjamin Meier1, Jaime Bosch3,4, Karel Caca1,3.   

Abstract

PURPOSE: To determine safety and efficacy of transjugular portal vein recanalization with creation of intrahepatic portosystemic shunt (PVR-TIPS) in patients with chronic non-cirrhotic, non-malignant portal vein thrombosis (PVT).
METHODS: This retrospective study includes 17 consecutive patients with chronic non-cirrhotic PVT (cavernous transformation n = 15). PVR-TIPS was indicated because of variceal bleeding (n = 13), refractory ascites (n = 2), portal biliopathy with recurrent cholangitis (n = 1), or abdominal pain (n = 1). Treatment consisted of a combination of transjugular balloon angioplasty, mechanical thrombectomy, and-depending on extent of residual thrombosis-transjugular intrahepatic portosystemic shunt and additional stenting of the portal venous system.
RESULTS: Recanalization was successful in 76.5 % of patients despite cavernous transformation in 88.2 %. Both 1- and 2-year secondary PV and TIPS patency rates were 69.5 %. Procedure-related bleeding complications occurred in 2 patients (intraperitoneal bleeding due to capsule perforation, n = 1; liver hematoma, n = 1) and resolved spontaneously. However, 1 patient died due to subsequent nosocomial pneumonia. During follow-up, 3 patients with TIPS occlusion and PVT recurrence experienced portal hypertensive complications.
CONCLUSIONS: PVR-TIPS is safe and effective in selected patients with chronic non-cirrhotic PVT. Due to technical complexity and possible complications, it should be performed only in specialized centers with high experience in TIPS procedures. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Year:  2017        PMID: 29113006     DOI: 10.1055/s-0043-121348

Source DB:  PubMed          Journal:  Z Gastroenterol        ISSN: 0044-2771            Impact factor:   2.000


  6 in total

1.  Current Indications and Long-Term Outcomes of Surgical Portosystemic Shunts in Adults.

Authors:  Indrani Sen; Lavanya Yohanathan; Jussi M Kärkkäinen; David M Nagorney
Journal:  J Gastrointest Surg       Date:  2020-05-18       Impact factor: 3.452

Review 2.  Interventional Management of Portal Hypertension in Cancer Patients.

Authors:  Max Kabolowsky; Lyndsey Nguyen; Brett E Fortune; Ernesto Santos; Sirish Kishore; Juan C Camacho
Journal:  Curr Oncol Rep       Date:  2022-08-12       Impact factor: 5.945

3.  Interventional recanalization therapy in patients with non-cirrhotic, non-malignant portal vein thrombosis: comparison between transjugular versus transhepatic access.

Authors:  Nabeel Mansour; Osman Öcal; Mirjam Gerwing; Michael Köhler; Sinan Deniz; Hauke Heinzow; Christian Steib; Martin K Angele; Max Seidensticker; Jens Ricke; Moritz Wildgruber
Journal:  Abdom Radiol (NY)       Date:  2022-01-12

Review 4.  Optimal Treatment for Patients With Cavernous Transformation of the Portal Vein.

Authors:  Bo Wei; Zhiyin Huang; Chengwei Tang
Journal:  Front Med (Lausanne)       Date:  2022-03-24

5.  Portal vein recanalisation alone to treat severe portal hypertension in non-cirrhotic patients with chronic extrahepatic portal vein obstruction.

Authors:  Florent Artru; Naik Vietti-Violi; Christine Sempoux; Joana Vieira Barbosa; Fabio Becce; Nelly Sah; Astrid Marot; Pierre Deltenre; Eleni Moschouri; Montserrat Fraga; Arnaud Hocquelet; Rafael Duran; Darius Moradpour; Pierre-Emmanuel Rautou; Alban Denys
Journal:  JHEP Rep       Date:  2022-05-25

6.  Whole clinical process in a patient with portal hypertensive biliopathy: a case report.

Authors:  Yimin Ma; Rencheng Cai; Duanming Zhuang; Yuehua Tang; Youhong Cao; Xiaoping Wang; Zhenguo Qiao
Journal:  J Int Med Res       Date:  2020-03       Impact factor: 1.671

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.